Renca-CAIX tumor-bearing mice were randomized to receive 12, 18, or 24 MBq [177Lu]Lu-DOTA-hG250 (with estimated tumor-absorbed doses of 29, 44, and 59 Gy, respectively), or saline. This evidence concerns the gene CA9 and neoplasm.